Upon progression of TB disease, vitD3, as well as LL-37 itself, may contribute to dampening an excessive inflammatory response to Mtb by reducing the production of pro-inflammatory cytokines and promoting anti-inflammatory responses [16,17,18,19]. Here, CAMP is linked to tuberculosis.